Min Zhong

Min Zhong

Auto-generated profile, based on publicly available information

Min Zhong

Department of Respiratory Emergency and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, PR China.

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Nuclear Medicine and Biology
Verified
Journal Article
Open access
YZYi Zhang
Yi Zhang
BKBijoy Kundu
Bijoy Kundu
MZMin Zhong
Min Zhong
THTao Huang
Tao Huang
JLJing Li
Jing Li
Weibin ShiWeibin Shi
Weibin Shi
Macrophages are a major inflammatory cell type involved in the development and progression of many important chronic inflammatory diseases. We previously found that apolipoprotein E-deficient (Apoe(-/-)) mice with the C57BL/6 (B6) background develop type 2 diabetes mellitus (T2DM) and accelerated atherosclerosis when fed a Western diet and that there are increased macrophage infiltrations in pancreatic islets and aorta. The formyl peptide receptor 1 (FPR1) is abundantly expressed on the surface of macrophages. The purpose of this study was to evaluate the applicability of cinnamoyl-F-(D)L-F-(D)L-F (cFLFLF), a natural FPR1 antagonist, to detection of macrophages in the pancreatic islets and aorta. (64)Cu labeled cFLFLF and (18)F-fluorodeoxyglucose (FDG) were administered to mice with or without T2DM. Diabetic mice showed an increased (18)FDG uptake in the subcutaneous fat compared with control mice, but pancreatic uptake was minimal for either group. In contrast, diabetic mice exhibited visually noticeable more cFLFLF-(64)Cu retention in pancreas and liver than control mice. The heart and pancreas isolated from diabetic mice contained more macrophages and showed stronger PET signals than those of control mice. Flow cytometry analysis revealed the presence of macrophages but not neutrophils in pancreatic islets. Real-time PCR analysis revealed much higher FPR1 expression in pancreatic islets of diabetic over control mice. Autoradiography and immunohistochemical analysis confirmed abundant FPR1 expression in atherosclerotic lesions. Thus, (64)Cu-labeled cFLFLF peptide is a more effective PET agent for detecting macrophages compared to FDG.

21 February 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
LZLing Zhou
Ling Zhou
HWHeng Wang
Heng Wang
MZMin Zhong
Min Zhong
ZFZhi Fang
Zhi Fang
YLYi Le
Yi Le
ZFZiling Fang
Ziling Fang
Background. Aberrant expression of tripartite motif 11 (TRIM11) and the Wnt/β-catenin pathway are essential for facilitating tumorigenesis and progression in multiple types of cancer. Aim. To investigate the molecular changes linking the dysregulation of TRIM11 and Wnt/β-catenin pathway activation in gastric cancer (GC) progression. Methods. The expression levels of TRIM11 were detected in GC tissues and cells by immunohistochemistry and western blotting. The role of TRIM11 in the growth, proliferation, and invasion of gastric cancer cells was observed by a series of cell functional experiments and further verified in vivo. Co-immunoprecipitation (Co-IP), immunofluorescence, cycloheximide, and western blotting assays and other experiments were conducted to explore the mechanisms of TRIM11 underlying the regulation of the Wnt/β-catenin pathway. For further verification, rescue experiments were performed by cotransfection of TRIM11 and Axin1 siRNA in GC cells. Results. Using Co-IP assays, we identified TRIM11 as a potent binding partner of Axin1 in GC cells. Elevated TRIM11 levels were significantly correlated with unfavorable clinical outcomes and poor survival in patients with GC. In addition, TRIM11 promoted the cell proliferation and invasion capacities of GC cells in vitro and tumor growth in vivo. Mechanistic investigations revealed that TRIM11 destabilized Axin1 protein by interacting with Axin1, thus inducing the activation of the Wnt/β-catenin pathway. Moreover, we found that the oncogenic effects of TRIM11 on GC cells were partly mediated by suppression of Axin1. Furthermore, the protein expression of TRIM11 and Axin1 was negatively correlated in GC tissues. Conclusion. Collectively, our findings not only establish a pivotal TRIM11-Axin1-β-catenin axis in driving GC progression but also indicate that TRIM11 serves as a valuable therapeutic target for the treatment of GC patients.

1 March 2009 in Cancer Letters
Verified
Journal Article
Closed access
EKEun Jung Kim
Eun Jung Kim
ZCZhong Min Che
Zhong Min Che
YPYong-Jin Park
Yong-Jin Park
YHYoung Sun Hwang
Young Sun Hwang
KKKi Yeol Kim
Ki Yeol Kim
JKJin Kim
Jin Kim

27 March 2026 in Cell Death Discovery
Verified
Journal Article
Open access
YZYing Zha
Ying Zha
HHHui Huang
Hui Huang
YLYulian Liu
Yulian Liu
MWMengzhi Wan
Mengzhi Wan
QYQinqin Yao
Qinqin Yao
MZMin Zhong
Min Zhong
Radioresistance remains a major obstacle in the treatment of non-small cell lung cancer (NSCLC). This study investigated the coordinated regulation of TFAM, FOXO3, and NRIP1 in NSCLC radioresistance. Radioresistant cell lines (A549-RR and H157-RR) were established to examine the effects of silencing these factors on cellular responses to radiation. In vivo, the impact of FOXO3 knockdown on tumor growth under irradiation was evaluated using A549-RR xenografts. Results show that TFAM expression was elevated in radioresistant cells, and its knockdown significantly restored radiosensitivity. ChIP-qPCR demonstrated direct FOXO3 binding to TFAM regulatory regions, establishing FOXO3 as an upstream transcriptional activator of TFAM. Silencing FOXO3 reduced TFAM expression and enhanced radiosensitivity, whereas LOM612, a FOXO nuclear relocator, promoted FOXO3 nuclear accumulation, upregulated TFAM, and reduced radiosensitivity. NRIP1 deficiency constrains FOXO3-dependent regulation of TFAM. Restoring NRIP1 selectively enhanced TFAM without affecting FOXO3 abundance, indicating its role as a coactivator. Co-immunoprecipitation confirmed FOXO3/NRIP1 interaction in NSCLC cells, with stronger interactions observed in radioresistant cells. Accordingly, NRIP1 silencing decreased TFAM levels and increased radiosensitivity. In vivo, FOXO3 knockdown markedly suppressed A549-RR tumor growth and improved radiotherapy response. Collectively, these findings indicate that nuclear accumulation of FOXO3 drives NSCLC radioresistance by transcriptionally upregulating TFAM, with NRIP1 enhancing this regulatory activity. Targeting FOXO3 may represent a promising strategy to enhance radiosensitivity in NSCLC.